MORGAN STANLEY - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 111 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,004,653
+488.0%
436,408
+323.0%
0.00%
Q2 2023$1,701,454
-56.0%
103,181
-52.4%
0.00%
Q1 2023$3,864,519
-45.5%
216,621
-11.1%
0.00%
-100.0%
Q4 2022$7,096,107
+25.8%
243,685
+5.9%
0.00%0.0%
Q3 2022$5,639,000
+215.4%
230,197
-46.6%
0.00%
Q2 2022$1,788,000
-39.2%
430,747
+68.6%
0.00%
Q1 2022$2,943,000
+9.9%
255,492
-4.8%
0.00%
Q4 2021$2,678,000
-0.2%
268,363
+30.6%
0.00%
Q3 2021$2,684,000
-69.3%
205,466
-54.0%
0.00%
-100.0%
Q2 2021$8,744,000
+307.6%
446,606
+342.8%
0.00%
Q1 2021$2,145,000
+43.7%
100,849
+100.9%
0.00%
Q4 2020$1,493,000
+339.1%
50,206
+220.2%
0.00%
Q3 2020$340,000
-38.0%
15,679
-36.1%
0.00%
Q2 2020$548,000
+224.3%
24,551
+121.2%
0.00%
Q1 2020$169,000
-87.5%
11,100
-81.1%
0.00%
Q4 2019$1,352,000
+393.4%
58,874
+362.2%
0.00%
Q3 2019$274,000
+585.0%
12,739
+588.2%
0.00%
Q2 2019$40,000
-68.5%
1,851
-59.8%
0.00%
Q1 2019$127,000
-81.6%
4,609
-82.0%
0.00%
Q4 2018$689,000
-11.3%
25,614
-3.9%
0.00%
Q3 2018$777,000
-16.2%
26,652
-10.1%
0.00%
Q2 2018$927,000
+177.5%
29,646
+76.7%
0.00%
Q1 2018$334,000
-56.9%
16,780
-37.0%
0.00%
Q4 2017$775,00026,6470.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$11,875,0002.75%
RA Capital Management 4,871,067$63,616,0000.88%
NEA Management Company, LLC 4,912,306$64,155,0000.76%
Samsara BioCapital, LLC 300,293$3,922,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,989,625$25,985,0000.51%
Baker Brothers Advisors 3,863,239$50,454,0000.22%
ACT CAPITAL MANAGEMENT, LLC 31,000$405,0000.21%
Rock Springs Capital Management LP 612,180$7,995,0000.17%
GILDER GAGNON HOWE & CO LLC 1,496,424$19,543,0000.10%
FEDERATED HERMES, INC. 3,011,053$39,324,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders